BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 26669915)

  • 1. Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: Prevalence and Predictors.
    Pérez-Peñate GM; Rúa-Figueroa I; Juliá-Serdá G; León-Marrero F; García-Quintana A; Ortega-Trujillo JR; Erausquin-Arruabarrena C; Rodríguez-Lozano C; Cabrera-Navarro P; Ojeda-Betancor N; Gómez-Sánchez MÁ
    J Rheumatol; 2016 Feb; 43(2):323-9. PubMed ID: 26669915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.
    Rotondo C; Praino E; Nivuori M; di Serio F; Lapadula G; Iannone F
    Int J Rheum Dis; 2017 Jan; 20(1):90-96. PubMed ID: 26218502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
    Allanore Y; Borderie D; Avouac J; Zerkak D; Meune C; Hachulla E; Mouthon L; Guillevin L; Meyer O; Ekindjian OG; Weber S; Kahan A
    Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis.
    Cavagna L; Caporali R; Klersy C; Ghio S; Albertini R; Scelsi L; Moratti R; Bonino C; Montecucco C
    J Rheumatol; 2010 Oct; 37(10):2064-70. PubMed ID: 20634241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining the necessity for right heart catheterization in pulmonary hypertension associated with connective tissue diseases assessed by echocardiography.
    Choi JH; Joo SJ; Kim J
    Int J Rheum Dis; 2016 Jan; 19(1):65-73. PubMed ID: 26820839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of uric acid in systemic lupus erythematosus is associated with pulmonary hypertension.
    Kim KJ; Baek IW; Park YJ; Yoon CH; Kim WU; Cho CS
    Int J Rheum Dis; 2015 Jun; 18(5):524-32. PubMed ID: 24428867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary hypertension associated with rheumatic diseases: baseline characteristics from the Korean registry.
    Jeon CH; Chai JY; Seo YI; Jun JB; Koh EM; Lee SK;
    Int J Rheum Dis; 2012 Oct; 15(5):e80-9. PubMed ID: 23083052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of heart rate recovery in female patients with pulmonary arterial hypertension due to systemic lupus erythematosus.
    Yang GL; Guo J; Pudasaini B; Yuan P; Gong SG; Wang L; Zhao QH; Yang WL; Jiang R; Zhou C; Liu JM
    Clin Respir J; 2019 Sep; 13(9):545-554. PubMed ID: 31295761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: Baseline characteristics and risk factors.
    Zhang N; Li M; Qian J; Wang Q; Zhao J; Yang Z; Tian Z; Zhang X; Zuo X; Zhang M; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Wei W; Zeng X
    Int J Rheum Dis; 2019 May; 22(5):921-928. PubMed ID: 30746850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
    Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M
    Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of the N-terminal pro-brain-type natriuretic peptide response to exercise with disease severity in therapy-naive pulmonary arterial hypertension: a cohort study.
    Kutsch J; Faul C; von Scheidt W; Schwaiblmair M; Berghaus TM
    Respir Res; 2018 Jan; 19(1):8. PubMed ID: 29334941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Features associated with pulmonary arterial hypertension in Chinese hospitalized systemic lupus erythematosus patients.
    Xu SZ; Yan Liang ; Li XP; Li XM; Shuai ZW; Leng RX; Pan HF; Ye DQ
    Clin Rheumatol; 2018 Jun; 37(6):1547-1553. PubMed ID: 29520672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of exercise capacity in female systemic lupus erythematosus associated pulmonary arterial hypertension patients.
    Pudasaini B; Yang GL; Yang C; Guo J; Yuan P; Wen-Lan Y; Zhang R; Wang L; Zhao QH; Gong SG; Jiang R; Chen TX; Wei X; Liu JM
    BMC Cardiovasc Disord; 2018 Mar; 18(1):56. PubMed ID: 29566672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
    Thakkar V; Stevens WM; Prior D; Moore OA; Byron J; Liew D; Patterson K; Hissaria P; Roddy J; Zochling J; Sahhar J; Nash P; Tymms K; Celermajer D; Gabbay E; Youssef P; Proudman SM; Nikpour M
    Arthritis Res Ther; 2012 Jun; 14(3):R143. PubMed ID: 22691291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors for pulmonary arterial hypertension in end-stage renal disease patients undergoing continuous ambulatory peritoneal dialysis.
    Zhang L; Zhao S; Ma J; Gong J; Qiu G; Ren Y; Zen Y; Shi Y
    Ren Fail; 2016 Jun; 38(5):815-21. PubMed ID: 26888091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Anemic Hypoxia and Increased Pulmonary Artery Systolic Pressure in Patients With Systemic Lupus Erythematosus.
    Kim KJ; Baek IW; Yoon CH; Kim WU; Cho CS
    Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1702-11. PubMed ID: 26018410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial stiffness, antiphospholipid antibodies, and pulmonary arterial hypertension in systemic lupus erythematosus.
    Lee JH; Im Cho K
    J Cardiol; 2014 Dec; 64(6):450-5. PubMed ID: 24755203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal brain natriuretic peptide as a diagnostic test in cirrhotic patients with pulmonary arterial hypertension.
    Bernal V; Pascual I; Esquivias P; García-Gil A; Mateo JM; Lacambra I; Serrano MT; Simón MA
    Transplant Proc; 2009 Apr; 41(3):987-8. PubMed ID: 19376405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of exercise pulmonary arterial hypertension in scleroderma.
    Callejas-Rubio JL; Moreno-Escobar E; de la Fuente PM; Pérez LL; Fernández RR; Sánchez-Cano D; Mora JP; Ortego-Centeno N
    J Rheumatol; 2008 Sep; 35(9):1812-6. PubMed ID: 18634147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma N-terminal pro-brain natriuretic peptide levels are positively correlated with pulmonary arterial pressure in atrial septal defect patients.
    Li ZF; Zhou DX; Wang QB; Pan WZ; Zhang L; Ge JB
    Regul Pept; 2013 May; 183():13-6. PubMed ID: 23499807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.